HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Setiady, Y. Y. Articles by Tung, K. S. K. Search for Related Content PubMed PubMed Citation Articles by Setiady, Y. Y. Articles by Tung, K. S. K.

Requirements of NK Cells and Proinflammatory Cytokines in T Cell-Dependent Neonatal Autoimmune Ovarian Disease Triggered by Immune Complex¹

Yulius Y. Setiady^2,*, Patcharin Pramoonjago^* and Kenneth S. K. Tung^*,

^* Departments of Pathology and Microbiology, University of Virginia, Charlottesville, VA 22908

A model of neonatal autoimmune disease has been described recently in which an epitope-specific autoantibody to murine zona pellucida 3 induces severe ovarian disease in neonatal, but not adult, mice (neonatal AOD). The autoantibody forms immune complex with endogenous ovarian zona pellucida 3, and a pathogenic CD4⁺ T cell response is triggered. The basis for the predominant neonatal susceptibility has not been clarified. In this study innate immunity, including neonatal NK cells, in neonatal AOD was investigated. Neonatal spleen contained readily detectable NK1.1⁺TCRV^–, but not NK1.1⁺TCRV⁺, cells. Ab depletion of NK1.1⁺TCRV^– cells inhibited neonatal AOD development. Moreover, in adoptive transfer of neonatal AOD, recipient disease was ameliorated when either donor or recipient NK cells were depleted. Thus, NK cells operate in both induction and effector phases of the disease. IFN- was produced by neonatal NK cells in vivo, and it may be important in neonatal AOD. Indeed, ovaries with neonatal AOD expressed high levels of IFN- and TNF- which correlated with disease severity, and the disease was inhibited by IFN- or TNF- Ab. Importantly, disease was enhanced by recombinant IFN-, and treatment of T cell donors with IFN- Ab also significantly reduced adoptive transfer of neonatal AOD. Finally, neonatal AOD was ameliorated in mice deficient in FcRIII and was enhanced in FcRIIB-deficient mice. We conclude that neonatal NK cells promote pathogenic T cell response at multiple stages during neonatal autoimmune disease pathogenesis. Also operative in neonatal AOD are other mediators of the innate system, including proinflammatory cytokines and FcRIII signaling.

This article has been cited by other articles:

				S. SKURKOVICH and B. SKURKOVICH Anticytokine Therapy, Especially Anti-Interferon-{gamma}, as a Pathogenetic Treatment in TH-1 Autoimmune Diseases Ann. N.Y. Acad. Sci., June 1, 2005; 1051(1): 684 - 700. [Abstract] [Full Text] [PDF]